Hypolipidemic efficacy of Ocimum sanctum in the prevention of atherogenesis in male albino rabbits

Pharmacologyonline

Volumn 2, Issue , 2007, Pages 115-127

  Samak, Geetha ^a   Rao, Muddanna S ^b   Kedlaya, Rajendra ^b   Vasudevan, D M ^c  

^a DVS College of Arts and Science   (India)

^b KASTURBA MEDICAL COLLEGE   (India)

^c AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Atherogenesis; Atheroma; Atherosclerosis; Hypolipidemic; Ocimum sanctum

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OCIMUM SANCTUM EXTRACT; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AQUEOUS SOLUTION; ARTICLE; ATHEROGENESIS; ATHEROMA; ATHEROSCLEROSIS; BASIL; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG ISOLATION; DRUG SOLUTION; HISTOPATHOLOGY; LIPID BLOOD LEVEL; LIPID LIVER LEVEL; MALE; NONHUMAN; RABBIT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 34548539683     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Satyavathi GV, Gupta KA, Tandon N (Edn.). Ocimum Linn. Medicinal plants of India, ICMR. New Delhi, 1987; 2: 354.
2. Rai V, Iyer U, Mani U V. Effect of tulasi (Ocimum sanctum) leaf powder supplementation on blood sugar levels, serum lipids in diabetic rats. Plants Foods Hum Nutr 1997;50:9.
3. Hussain EHMA, Jamil K, Rao M. Hypoglycemic,hypolipidemic and antioxidant properties of Tulsi(Ocimum sanctum Linn) on Streptozotocin induced Diabetes in rats. Indian Journal of Clinical Biochemistry 2001; 16[2]:190-194.
4. Angshula Sarkar, Lavania SC, Pandey DN, Pant MC. Changes in blood lipid profile after administration of Ocimum sanctum (Tulsi) leaves in the normal albino rabbits. Indian J Physiol Pharmacol 1994; 38[4]: 311-312.
5. Geetha S, Kedlaya R, Vasudevan D M. Superoxide and Hydrogen Peroxide Scavenging action of Ocimum sanctum extracts and their fractions. Natural Product Sciences 2003; 9(4): 223-225.
6. Geetha S, Kedlaya R, Vasudevan D M. Inhibition of lipid peroxidation by botanical extracts of Ocimum sanctum: In vivo and in vitro studies.Life Sciences, 2004; 76:21-28
7. Davies M J. Woolf N., Atherosclerosis: what is it and why does it occur? Br Heart J, 1993; 69:S3-S11.
8. Ridker P M, Genest J, Libby P. Risk Factors for Atherosclerotic Disease. A Text Bock of Cardiovascular Medicine.Harcount International Edition WB Saunders Company, Philadelphia 2001: 1010-1041
9. Witztum JL, The Oxidation hypothesis of atherosolerosis. The Lancet, 1994; 344:793-795
10. Ganasoundari A, Uma Devi P, Rao BSS. Enhancement of bone marrow radioprotection and reduction of WR-2721 toxicity by Ocimum sanctum. Mutation Research 1998; 397: 303-312.
11. Pagalia DE, and Valentine WN. Studies on the quantitative characterization of erythrocyte peroxidase. J. Lab. Clin. Med. 1967; 70:158-169.
12. Aebi H E, Catalase. Methods in Enzymatic Analysis. 1074; 3:273-28413.
13. Friedwald WT, Levy R T, Friederickson DS. Estimation of plasma low denisity lipoprotein cholesterol concentration with out use of the preparative ultracentrifuge. Clin. Chem, 1972; 18:449-502.
14. Berg JE, Hostmark AT. Cardiovascular risk determination: discrepancy between total cholesterol evaluation and two compound laboratory indices in Norway. Journal of Epidemiology and Community Health 1994; 48: 338-343
15. Varley H In:Gowenlock A.H(ed);Varley's practical clinical biochemistry, 4th edn; London. Heinemann Medical Book. 1967; 813.
16. Jose M; Barry F; Harry G, Simple Manual Procedure for Determination of Serum Triglycerides. Clin.chem 1975; 21:768-770.
17. Esterbauer H, Schmidt R, Hayn M, Advances in Pharmacology Edt. Sies H. Academic Press, London, 1997; 38:425
18. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond Cholesterol: Modification of low density lipoprotein that increase its atherogenisity. N Engl J Med 320: 915-924, 1989.
19. Stix.G., Signal Jammer, Scientific American 2003 July:29-31.
20. Wissler RW, Vasselinovitch D. Can Atherosclerotic. PlaqesRegress?Anatomic andBiochemicalEvidence from Nonhuman Animal Models. The American Journal of Cardiology1990; 65: 33F-40F.
21. Skaltsa H., Tzakou O., Singh M., Polyphenols of Ocimum sanctum from Suriname. Pharmaceutical Biology 1999;37(1): 92-94.
22. Norr H, Wagner H, New Constituents from Ocimum sanctum. Planta Medica 1992; 58: 574.
23. Fuhrman B, Rosenblat M, Hayek T, Coleman R., Aviram M, Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic apolipoprotein E- deficient Mice. Journal of Nutrition 2000; 130: 1124-1231
24. Alcocer F, Whitley D, Salazan Gonazalez JF, Jordan WD, Sellers MT, Eckhoff DE, Suzuki K, Macrae C, Bland KI, Quercetin inhibits human vascular smooth muscle cell proliferation and migration. Surgery 2002;131(2):198-204.
25. Mojzisova G, Kuchta M, Dietary Flavonoids and Risk of Coronary Heart Disease Physiol Res 200 1; 50(6): 529-535.